Mania, Depression, Mixed Episodes: The Spectrum of Bipolar Disorder
neuroscienceCME WebcastPremiere Date: Monday, February 12, 2018
This activity offers CE credit for:%>
- Physicians (CME)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, February 12, 2019
Note: Credit Is No Longer Available
|Mark A. Frye, MD
Professor and Chair, Department of Psychiatry and Psychology
Stephen & Shelly Jackson Family Professorship in Individualized Medicine
Director, Mayo Clinic Depression Center
This video is a replay of a plenary session from the 10th Annual Chair Summit Master Class for Neuroscience Professional Development held in New Orleans, LA on November 16-18, 2017.
At the end of this CE activity, participants should be able to:
- Initiate management strategies for the acute symptoms in bipolar disorder that promote remission relapse and functional recovery.
- Select treatment strategies for the acute symptoms in bipolar disorder that reduce the risk of adverse metabolic consequences.
This activity is supported by CME Outfitters, LLC.
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other nonphysical healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Frye reports that he receives grant support from AssureRX Health Inc.; Janssen Research & Development, LLC; Mayo Foundation for Medical Education and Research; Myriad Genetics; National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Mental Health (NIMH); and Pfizer, Inc. He is a consultant for Janssen Research & Development, LLC; Mitsubishi Tanabe Pharma Corporation; Myriad Genetics; Neuralstem Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; and Teva Pharmaceuticals. His employer, Mayo Clinic, has a financial interest in AssureRX and the technology referenced in this presentation.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Daniela V. DiBiase, MS (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained fro the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).